Despite having a great importance in ovarian cancer, CA125 does not display an elevated serum level in over 50% of the women with early stage tumors because this antigen is not expressed in most early stage ovarian tumors [1,76-79]. The gene discussed is MUC16; the disease is ovarian cancer.